Clinical trial registry record

Metformin in Longevity Study (MILES).

A registered PHASE4 study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.

Registry ID
NCT02432287
Last registry update
May 21, 2021
Status
Completed
Phase
PHASE4
Sponsor
Albert Einstein College of Medicine
Enrollment
16
Countries
United States
Match confidence
80%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered PHASE4 study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record matched · 80% confidence

Published automatically with 80% topic confidence after controlled-term evaluation.

  • Metformin · 80%Legacy trial evaluated automatically against controlled title, summary, and longevity-context rules.

Source quality 100% · freshness 50%. These are automated routing signals, not medical or evidence-strength ratings.